Mora L, Zarate A, Serra-Aracil X, Pallisera A, Serra S, Navarro-Soto S

Language: Spanish
References: 20
Page: 140-147
PDF size: 438.10 Kb.

ABSTRACT

Background: The gold standard of rectal surgery remains total mesorrectal excision (ETM) in which laparoscopy is applied for its advantages. The attempt to avoid 17% conversion rate implies that transanal techniques are applied. Transanal ETM (TaETM) is performed by experimental groups with good oncological and morbimortality results. Objective: This study determines the quality of life and the anorectal function of these patients. Method: Observational study of two cohorts comparing patients undergoing rectal tumor surgery using TaETM or conventional ETM after a minimum of six months of intestinal transit reconstruction. EORTC-30, EORTC-29 quality of life questionnaires and the anorectal function assessment questionnaire (LARS score) are applied. General variables are also collected. Results: 31 patients between 2011 and 2014: 15 ETM group and 16 TaETM. We do not find statistically significant differences in quality of life questionnaires or in anorectal function. Statistically significant general variables: longer surgical time in the TaETM group. Nosocomial infection and minor suture failure in the TaETM group. Conclusion: The performance of TaETM achieves the same results in terms of quality of life and anorectal function as conventional ETM.

REFERENCES

1. Heald RJ. The “HolyPlane” of rectal surgery. J R Soc Med. 1988;8:503-8.

2. Van der Pas MH, Haglind E, Cuesta MA, Lacy AM, Hop WC, Bonjer HJ, et al. Colorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomisedphase 3 trial. Lancet Oncol. 2013;14:210-8.

3. Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010;24:1205-10.

4. Serra-Aracil X, Mora-López L, Casalots A, Pericay C, Guerrero R, Navarro- Soto S. Hybrid NOTES: TEO for transanal total mesorrectal excision: intracorporeal resection and anastomosis. Surg Endosc. 2016;30:346-54.

5. Leroy J, Barry BD, Melani A, Mutter D, Marescaux J. No-scar transanal total mesorrectal excision: the last step to pure NOTES for colorectal surgery. JAMA. Surg. 2013;148:226-30.

6. Horgan S, Cullen JP, Talamini MA, Mintz Y, Ferreres A, Jacobsen GR, et al. Natural orifice surgery: initial clinical experience. Surg Endosc. 2009;23:1512-8.

7. Lacy AM, Rattner DW, Adelsdorfer C, Tasende MM, Fernández M, Delgado S, et al. Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: ‘‘down-to-up’’ total mesorectal excision (TME) – short-term outcomes in the first 20 cases. Surg Endosc. 2013;27:3165-72.

8. Fernández-Hevia M, Delgado S, Castells A, Tasende M, Momblan D, Díaz del Gobbo G, et al. Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Surg. 2015;261:221-7.

9. Arraras Urdaniz JI, Villafranca Iturre E, Arias de la Vega F, Domínguez Domínguez MA, Lainez Milagro N, Manterola Burgaleta A, et al. The EORTC quality of life questionnaire QLQ-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Arch Esp Urol. 2008;61:949-54.

10. Arraras J, Suárez J, Arias de la Vega F, Vera R, Asín G, Arrazubi V, et al. The EORTC Quality of Life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clin Transl Oncol. 2011;13:50-6.

11. Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255:922-8.

12. Juul T, Ahlberg M, Biondo S, Emmertsen KJ, Espin E, Jiménez LM, et al. International validation of the low anterior resection syndrome score. Ann Surg. 2014;259:728-34.

13. Kneist W, Junginger T. Residual urine volume after total mesorectal excision: an indicator of pelvic autonomic nerve preservation? Results of a case-control study. Colorectal Dis. 2004;6:432-7.

14. Shah EF, Huddy SPJ. A prospective study of genito-urinary dysfunction after surgery for colorectal cancer. Colorectal Dis. 2001;3:122-5.

15. Maas CP, Moriya Y, Steup WH, Klein Kranenbarg E, van de Velde CJ. A prospective study on radical and nerve-preserving surgery for rectal cancer in the Netherlands. Eur J Surg Oncol. 2000;26:751e757.

16. Enker WE, Merchant N, Cohen AM, Lanouette NM, Swalon C, Guillem J, et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg. 1999;230:544-52; discussion 552-4.

17. Bregendahl S, Emmertsen KJ, Lous J, Laurberg S. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal Dis. 2013;15:1130-9.

18. Mora López L, Serra Aracil X, Hermoso Bosch J, Rebasa P, Navarro Soto S. Study of anorectal function after transanal endoscopic surgery. Int J Surg. 2015;13:142-7.

19. Steinemann DC, Zerz A, Germann S, Lamm SH. Anorectal function and quality of life after transrectal rigid-hybrid natural orifice transluminal endoscopic sigmoidectomy. J Am Coll Surg. 2016;223:299-307.

20. Koedam TW, van Ramshorst GH, Deijen CL, Elfrink AK, Meijerink WJ, Bonjer HJ, et al. Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol. 2017;21:25-33.